Common Contracts
10 similar Employment Agreement contracts by Spyre Therapeutics, Inc., Aeglea BioTherapeutics, Inc., Oruka Therapeutics, Inc.
October 3, 2024 Arjun Agarwal c/o Oruka Therapeutics, Inc. Menlo Park, CA 94025 Re: Amended and Restated Employment Letter Agreement Dear Arjun:Employment Agreement • October 4th, 2024 • Oruka Therapeutics, Inc. • In vitro & in vivo diagnostic substances
On behalf of Oruka Therapeutics, Inc. (the “Company”), I am pleased to offer you a continuing position as Senior Vice President, Finance (the “Role”) pursuant to this letter agreement (the “Agreement”). Your Role commenced on March 22, 2024 pursuant to your letter agreement dated March 11, 2024. This Agreement will amend and restate that March 11, 2024 letter agreement, provided you accept this offer as indicated by your signature below, to be effective as of the date hereof.
October 3, 2024 Lawrence Klein c/o Oruka Therapeutics, Inc. Menlo Park, CA 94025 Re: Amended and Restated Employment Letter Agreement Dear Lawrence:Employment Agreement • October 4th, 2024 • Oruka Therapeutics, Inc. • In vitro & in vivo diagnostic substances
On behalf of the Board of Directors (the “Board”) of Oruka Therapeutics, Inc. (the “Company”), I am pleased to offer you a continuing position as Chief Executive Officer of the Company (“CEO”) and as a member of the Board pursuant to this letter agreement (the “Agreement”). Your position as CEO commenced on February 26, 2024 pursuant to your amended and restated letter agreement dated February 14, 2024. This Agreement will amend and restate that February 14, 2024 letter agreement provided you accept this offer as indicated by your signature below, to be effective as of the date hereof.
August 18, 2023 Heidy King-Jones Re: Offer of Employment Dear Heidy:Employment Agreement • March 1st, 2024 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Legal Officer and Corporate Secretary (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
November 22, 2023 Cameron Turtle Re: Amended and Restated Employment Letter Agreement Dear Cameron:Employment Agreement • February 5th, 2024 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Executive Officer of the Company (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below, to be effective November 22, 2023 (the “Effective Date”). This Agreement amends and restates that certain letter agreement date June 22, 2023.
August 10, 2023 Scott Burrows Re: Offer of Employment Dear Scott:Employment Agreement • December 22nd, 2023 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Financial Officer (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
November 22, 2023 Cameron Turtle Re: Amended and Restated Employment Letter Agreement Dear Cameron:Employment Agreement • December 22nd, 2023 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Executive Officer of the Company (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below, to be effective November 22, 2023 (the “Effective Date”). This Agreement amends and restates that certain letter agreement date June 22, 2023.
November 22, 2023 Cameron Turtle Re: Amended and Restated Employment Letter Agreement Dear Cameron:Employment Agreement • November 28th, 2023 • Spyre Therapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Executive Officer of the Company (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below, to be effective November 22, 2023 (the “Effective Date”). This Agreement amends and restates that certain letter agreement date June 22, 2023.
June 22, 2023 Cameron Turtle Re: Offer of Employment Dear Cameron:Employment Agreement • November 15th, 2023 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Operating Officer of the Company (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
August 10, 2023 Scott Burrows Re: Offer of Employment Dear Scott:Employment Agreement • November 15th, 2023 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Financial Officer (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
August 10, 2023 Scott Burrows Re: Offer of Employment Dear Scott:Employment Agreement • September 5th, 2023 • Aeglea BioTherapeutics, Inc. • Pharmaceutical preparations
On behalf of Aeglea BioTherapeutics, Inc. (the “Company”), I am very pleased to offer you a position as Chief Financial Officer (the “Role”) pursuant to this letter agreement (the “Agreement”), provided you accept such offer as indicated by your signature below.
